Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) were up 9.1% during trading on Tuesday . The company traded as high as GBX 1.80 ($0.02) and last traded at GBX 1.80 ($0.02). Approximately 1,744,599 shares changed hands during mid-day trading, an increase of 4% from the average daily volume of 1,670,021 shares. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Stock Up 12.7 %
The firm has a market cap of £8.93 million, a price-to-earnings ratio of -225.40 and a beta of 0.38. The stock has a 50 day moving average of GBX 1.79 and a 200 day moving average of GBX 1.84.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- Most active stocks: Dollar volume vs share volume
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Double-Digit Gains Ahead? These 2 Cybersecurity Stocks Look Ready
- How to Most Effectively Use the MarketBeat Earnings Screener
- Will Falling Bond Yields Send These 2 Small Caps Soaring?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
